, Volume 36, Issue 6, pp 1453–1459 | Cite as

Valproic Acid Attenuates Lipopolysaccharide-Induced Acute Lung Injury in Mice

  • Mu-huo Ji
  • Guo-min Li
  • Min Jia
  • Si-hai Zhu
  • Da-peng Gao
  • Yun-xia Fan
  • Jing Wu
  • Jian-jun Yang


Valproic acid (VPA) has been shown to exert anti-inflammatory and antioxidant effects in a range of diseases including septic shock. However, the effects of VPA on lipopolysaccharide (LPS)-induced acute lung injury (ALI) remains not well understood. We found that VPA pretreatment attenuated the LPS-induced ALI, as evidenced by the reduced histological scores, myeloperoxidase activity, and wet-to-dry weight ratio in the lung tissues. This was accompanied by the downregulated nuclear factor kappa B (NF-κB) p65, nitric oxide, and inducible nitric oxide synthase in the lung tissues and the decreased levels of tumor necrosis factor alpha and interleukin-1β in the bronchoalveolar lavage fluid. Furthermore, VPA reduced the nuclear histone deacetylase (HDAC)3 expression whereas increased the cytoplasmic HDAC3 expression. Our results suggested that VPA attenuates the LPS-induced ALI via inhibiting the NF-κB activation probably through a mechanism depending on HDAC3 redistribution.


sepsis pro-inflammatory cytokine HDACs acute lung injury 



This work was supported by the Natural Science Foundation of Jiangsu Province (BK2012778).

Conflict of Interest

The authors have no potential conflicts of interest to disclose.


  1. 1.
    Rubenfeld, G.D., E. Caldwell, E. Peabody, J. Weaver, D.P. Martin, M. Neff, E.J. Stern, and L.D. Hudson. 2005. Incidence and outcomes of acute lung injury. The New England Journal of Medicine 353(16): 1685–1693.PubMedCrossRefGoogle Scholar
  2. 2.
    Ji, M.H., X.L. Zhu, F.F. Liu, G.M. Li, M. Tian, J. Wu, Y.X. Fan, N. Li, and J.J. Yang. 2012. Alpha 2A-adrenoreceptor blockade improves sepsis-induced acute lung injury accompanied with depressed high mobility group box-1 levels in rats. Cytokine 60(3): 639–645.PubMedCrossRefGoogle Scholar
  3. 3.
    Ji, M., R. Li, G.M. Li, Y. Fan, L. Dong, J. Yang, Y.G. Peng, and J. Wu. 2012. Effects of combined levosimendan and vasopressin on pulmonary function in porcine septic shock. Inflammation 35(3): 871–880.PubMedCrossRefGoogle Scholar
  4. 4.
    Li, Y., B. Liu, X. Gu, A.R. Kochanek, E.Y. Fukudome, Z. Liu, T. Zhao, W. Chong, Y. Zhao, D. Zhang, T.A. Libermann, and H.B. Alam. 2012. Creating a “pro-survival” phenotype through epigenetic modulation. Surgery 152(3): 455–464.PubMedCrossRefGoogle Scholar
  5. 5.
    Halili, M.A., M.R. Andrews, L.I. Labzin, K. Schroder, G. Matthias, C. Cao, E. Lovelace, R.C. Reid, G.T. Le, D.A. Hume, K.M. Irvine, P. Matthias, D.P. Fairlie, and M.J. Sweet. 2010. Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS. Journal of Leukocyte Biology 87(6): 1103–1114.PubMedCrossRefGoogle Scholar
  6. 6.
    Grabiec, A.M., S. Krausz, W. de Jager, T. Burakowski, D. Groot, M.E. Sanders, B.J. Prakken, W. Maslinski, E. Eldering, P.P. Tak, and K.A. Reedquist. 2010. Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue. Journal of Immunology 184(5): 2718–2728.CrossRefGoogle Scholar
  7. 7.
    Wu, C., A. Li, Y. Leng, Y. Li, and J. Kang. 2012. Histone deacetylase inhibition by sodium valproate regulates polarization of macrophage subsets. DNA and Cell Biology 31(4): 592–599.PubMedCrossRefGoogle Scholar
  8. 8.
    Liu, Z., Y. Li, B. Liu, D.K. Deperalta, T. Zhao, W. Chong, X. Duan, P. Zhou, G.C. Velmahos, and H.B. Alam. 2013. Synergistic effects of hypertonic saline and valproic acid in a lethal rat two-hit model. Journal of Trauma and Acute Care Surgery 74(4): 991–997.PubMedCrossRefGoogle Scholar
  9. 9.
    Kim, K., Y. Li, G. Jin, W. Chong, B. Liu, J. Lu, K. Lee, M. Demoya, G.C. Velmahos, and H.B. Alam. 2012. Effect of valproic acid on acute lung injury in a rodent model of intestinal ischemia reperfusion. Resuscitation 83(2): 243–248.PubMedCrossRefGoogle Scholar
  10. 10.
    Bai, G.Z., H.T. Yu, Y.F. Ni, X.F. Li, Z.P. Zhang, K. Su, J. Lei, B.Y. Liu, C.K. Ke, D.X. Zhong, Y.J. Wang, and J.B. Zhao. 2012. Shikonin attenuates lipopolysaccharide-induced acute lung injury in mice. Journal of Surgical Research 182(2): 303–311. doi: 10.1016/j.jss.2012.10.039.PubMedCrossRefGoogle Scholar
  11. 11.
    Li, G.M., M.H. Ji, X.J. Sun, Q.T. Zeng, M. Tian, Y.X. Fan, W.Y. Li, N. Li, and J.J. Yang. 2012. Effects of hydrogen-rich saline treatment on polymicrobial sepsis. Journal of Surgical Research 181(2): 279–286.PubMedCrossRefGoogle Scholar
  12. 12.
    Zhang, H., P. Neuhöfer, L. Song, B. Rabe, M. Lesina, M.U. Kurkowski, M. Treiber, T. Wartmann, S. Regnér, H. Thorlacius, D. Saur, G. Weirich, A. Yoshimura, W. Halangk, J.P. Mizgerd, R.M. Schmid, S. Rose-John, and H. Algül. 2013. IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality. The Journal of Clinical Investigation 123(3): 1019–1031.PubMedCrossRefGoogle Scholar
  13. 13.
    Park, W.Y., R.B. Goodman, K.P. Steinberg, J.T. Ruzinski, F. Radella 2nd, D.R. Park, J. Pugin, S.J. Skerrett, L.D. Hudson, and T.R. Martin. 2001. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 164(10 Pt 1): 1896–1903.PubMedCrossRefGoogle Scholar
  14. 14.
    Li, Y., and H.B. Alam. 2012. Creating a pro-survival and anti-inflammatory phenotype by modulation of acetylation in models of hemorrhagic and septic shock. Advances in Experimental Medicine and Biology 710: 107–133.PubMedCrossRefGoogle Scholar
  15. 15.
    Chen, X., I. Barozzi, A. Termanini, E. Prosperini, A. Recchiuti, J. Dalli, F. Mietton, G. Matteoli, S. Hiebert, and G. Natoli. 2012. Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proceedings of the National Academy of Sciences of the United States of America 109(42): E2865–E2874.PubMedCrossRefGoogle Scholar
  16. 16.
    Mullican, S.E., C.A. Gaddis, T. Alenghat, M.G. Nair, P.R. Giacomin, L.J. Everett, D. Feng, D.J. Steger, J. Schug, D. Artis, and M.A. Lazar. 2011. Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation. Genes & Development 25(23): 2480–2488.CrossRefGoogle Scholar
  17. 17.
    Yan, Q., R.J. Carmody, Z. Qu, Q. Ruan, J. Jager, S.E. Mullican, M.A. Lazar, and Y.H. Chen. 2012. Nuclear factor-κB binding motifs specify Toll-like receptor-induced gene repression through an inducible repressosome. Proceedings of the National Academy of Sciences of the United States of America 109(35): 14140–14145.PubMedCrossRefGoogle Scholar
  18. 18.
    Zhu, T., D.X. Wang, W. Zhang, X.Q. Liao, X. Guan, H. Bo, J.Y. Sun, N.W. Huang, J. He, Y.K. Zhang, J. Tong, and C.Y. Li. 2013. Andrographolide protects against LPS-induced acute lung injury by inactivation of NF-κB. PLoS One 8(2): e56407.PubMedCrossRefGoogle Scholar
  19. 19.
    Chen, Lf., W. Fischle, E. Verdin, and W.C. Greene. 2001. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 293(5535): 1653–1657.CrossRefGoogle Scholar
  20. 20.
    Winkler, A.R., K.N. Nocka, and C.M. Williams. 2012. Smoke exposure of human macrophages reduces HDAC3 activity, resulting in enhanced inflammatory cytokine production. Pulmonary Pharmacology & Therapeutics 25(4): 286–292.CrossRefGoogle Scholar
  21. 21.
    Ziesché, E., D. Kettner-Buhrow, A. Weber, T. Wittwer, L. Jurida, J. Soelch, H. Müller, D. Newel, P. Kronich, H. Schneider, O. Dittrich-Breiholz, S. Bhaskara, S.W. Hiebert, M.O. Hottiger, H. Li, E. Burstein, M.L. Schmitz, and M. Kracht. 2013. The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κB. Nucleic Acids Research 41(1): 90–109.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Mu-huo Ji
    • 1
  • Guo-min Li
    • 2
  • Min Jia
    • 1
  • Si-hai Zhu
    • 1
  • Da-peng Gao
    • 1
  • Yun-xia Fan
    • 2
  • Jing Wu
    • 1
  • Jian-jun Yang
    • 1
  1. 1.Department of Anesthesiology, Jinling Hospital, School of MedicineNanjing UniversityNanjingChina
  2. 2.Department of Anesthesiology and Intensive Care, Jintan HospitalJiangsu UniversityChangzhouChina

Personalised recommendations